Xometry (XMTR) Financials

$87.15 -0.81 (-0.92%)

Closing price 05/19/2026 04:00 PM Eastern

Extended Trading

$87.60 +0.45 (+0.52%)

As of 05/19/2026 07:44 PM Eastern

Annual Income Statements for Xometry

This table shows Xometry's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-31	-40	-61	-79	-67	-50	-62
Consolidated Net Income / (Loss)	-31	-31	-61	-79	-67	-50	-62
Net Income / (Loss) Continuing Operations	-31	-31	-61	-79	-67	-50	-62
Total Pre-Tax Income	-31	-31	-61	-79	-68	-50	-61
Total Operating Income	-31	-29	-59	-77	-74	-56	-46
Total Gross Profit	15	33	57	146	178	216	269
Total Revenue	80	141	218	381	463	546	687
Operating Revenue	80	141	218	381	463	546	687
Total Cost of Revenue	65	108	161	235	285	330	418
Operating Cost of Revenue	65	108	161	235	285	330	418
Total Operating Expenses	45	63	116	223	252	272	314
Selling, General & Admin Expense	8.02	12	35	58	71	65	72
Marketing Expense	15	23	39	84	94	108	123
Research & Development Expense	11	12	18	31	34	39	47
Other Operating Expenses / (Income)	10	14	24	49	52	59	72
Impairment Charge	1.72	1.59	0.00	0.82	0.40	0.08	0.05
Total Other Income / (Expense), net	-0.45	-1.87	-2.70	-1.92	5.76	5.73	-16
Interest Expense	0.24	1.09	0.85	4.42	4.78	4.75	4.91
Interest & Investment Income	0.00	0.00	1.02	4.69	12	11	8.97
Other Income / (Expense), net	-0.20	-0.78	-2.87	-2.18	-1.51	-0.76	-20
Income Tax Expense	-	0.00	0.00	0.04	-0.35	-0.02	0.59
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	-0.00	0.02	0.01	-0.00	-0.01
Basic Earnings per Share	($4.88)	($5.32)	($4.66)	($3.36)	($1.41)	($1.03)	($1.22)
Weighted Average Basic Shares Outstanding	6.35M	7.49M	52.64M	94.32M	47.91M	49.08M	50.81M
Diluted Earnings per Share	($4.88)	($5.32)	($4.66)	($3.36)	($1.41)	($1.03)	($1.22)
Weighted Average Diluted Shares Outstanding	6.35M	7.49M	52.64M	94.32M	47.91M	49.08M	50.81M
Weighted Average Basic & Diluted Shares Outstanding	6.35M	7.49M	26.32M	45.07M	48.58M	50.30M	51.82M

This table shows Xometry's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-12	-11	-17	-14	-10	-9.89	-15	-26	-12	-8.63	-5.27
Consolidated Net Income / (Loss)	-12	-11	-17	-14	-10	-9.90	-15	-26	-12	-8.64	-5.26
Net Income / (Loss) Continuing Operations	-12	-11	-17	-14	-10	-9.90	-15	-26	-12	-8.64	-5.26
Total Pre-Tax Income	-12	-11	-17	-14	-10	-9.94	-15	-26	-12	-8.02	-5.01
Total Operating Income	-13	-13	-18	-15	-11	-12	-15	-10	-11	-8.78	-5.22
Total Gross Profit	46	49	48	53	56	59	56	65	72	75	78
Total Revenue	119	128	123	133	142	149	151	163	181	192	205
Operating Revenue	119	128	123	133	142	149	151	163	181	192	205
Total Cost of Revenue	73	79	75	80	86	90	95	97	109	117	127
Operating Cost of Revenue	73	79	75	80	86	90	95	97	109	117	127
Total Operating Expenses	59	62	66	68	67	71	72	75	83	84	84
Selling, General & Admin Expense	15	14	15	16	16	17	17	17	19	19	21
Marketing Expense	23	25	27	27	27	27	26	30	33	34	32
Research & Development Expense	8.52	8.89	9.59	10	9.34	10	11	11	13	12	11
Other Operating Expenses / (Income)	13	13	14	14	15	16	17	18	18	19	20
Impairment Charge	0.15	-	-	-	0.00	0.08	0.00	-	0.05	-	0.00
Total Other Income / (Expense), net	1.33	1.43	1.25	1.58	1.31	1.59	0.32	-16	-0.56	0.75	0.21
Interest Expense	1.21	1.19	1.19	1.19	1.19	1.19	1.19	1.18	1.28	1.26	1.26
Interest & Investment Income	3.13	2.97	2.83	3.00	2.94	2.47	2.38	2.39	2.36	1.84	1.93
Other Income / (Expense), net	-0.60	-0.36	-0.39	-0.23	-0.44	0.31	-0.88	-17	-1.64	0.17	-0.46
Income Tax Expense	0.14	-0.56	0.00	-0.01	0.03	-0.04	0.00	-0.01	-0.02	0.61	0.25
Net Income / (Loss) Attributable to Noncontrolling Interest	0.01	-0.00	0.01	-0.01	0.00	-0.01	0.00	-0.00	0.00	-0.00	0.01
Basic Earnings per Share	($0.25)	($1.64)	($0.34)	($0.28)	($0.21)	($1.23)	($0.30)	($0.52)	($0.23)	($0.17)	($0.10)
Weighted Average Basic Shares Outstanding	47.99M	95.83M	48.58M	48.84M	49.28M	98.17M	50.34M	50.70M	50.92M	50.81M	51.91M
Diluted Earnings per Share	($0.25)	($1.64)	($0.34)	($0.28)	($0.21)	($1.23)	($0.30)	($0.52)	($0.23)	($0.17)	($0.10)
Weighted Average Diluted Shares Outstanding	47.99M	95.83M	48.58M	48.84M	49.28M	98.17M	50.34M	50.70M	50.92M	50.81M	51.91M
Weighted Average Basic & Diluted Shares Outstanding	45.39M	48.58M	46.12M	49.30M	49.56M	50.30M	50.68M	50.80M	51.25M	51.82M	52.60M

This table details how cash moves in and out of Xometry's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	25	20	26	-21	-12	-31	-7.24
Net Cash From Operating Activities	-27	-22	-69	-63	-30	-15	6.09
Net Cash From Continuing Operating Activities	-27	-22	-69	-63	-30	-15	6.09
Net Income / (Loss) Continuing Operations	-31	-31	-61	-79	-67	-50	-62
Consolidated Net Income / (Loss)	-31	-31	-61	-79	-67	-50	-62
Depreciation Expense	1.85	3.12	3.60	7.82	11	13	19
Amortization Expense	-0.04	0.00	0.00	1.72	1.86	1.86	2.10
Non-Cash Adjustments To Reconcile Net Income	3.54	3.95	13	33	38	36	61
Changes in Operating Assets and Liabilities, net	-1.48	1.97	-24	-26	-13	-15	-14
Net Cash From Investing Activities	-2.35	6.67	-213	-239	17	-20	-17
Net Cash From Continuing Investing Activities	-2.35	6.67	-213	-239	17	-20	-17
Purchase of Property, Plant & Equipment	-2.69	-4.19	-6.26	-14	-18	-18	-30
Acquisitions	-1.43	0.00	-175	0.00	-3.35	0.00	0.00
Purchase of Investments	-29	-18	-267	-284	-12	-19	-8.54
Sale of Property, Plant & Equipment	0.16	0.00	0.00	0.19	0.22	0.08	0.00
Sale and/or Maturity of Investments	30	29	235	59	50	17	22
Net Cash From Financing Activities	55	35	308	281	1.07	4.64	2.89
Net Cash From Continuing Financing Activities	55	35	308	281	1.07	4.64	2.89
Repayment of Debt	-0.50	-4.78	-16	-9.31	0.00	0.00	-225
Repurchase of Common Equity	0.00	0.00	-3.68	0.00	0.00	0.00	-8.08
Issuance of Debt	0.00	8.78	0.00	288	0.00	0.00	250
Other Financing Activities, net	0.29	0.51	2.32	2.78	1.07	4.64	-14
Effect of Exchange Rate Changes	-	-0.13	-0.06	-0.37	-0.23	-0.27	0.42
Cash Interest Paid	1.11	1.27	0.91	1.41	2.88	2.88	3.55

This table details how cash moves in and out of Xometry's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-12	9.05	-7.72	-24	-4.64	4.80	-6.73	1.24	4.09	-5.85	6.05
Net Cash From Operating Activities	-5.98	-1.29	-12	-9.10	-3.63	9.09	-3.69	-0.43	5.79	4.41	15
Net Cash From Continuing Operating Activities	-5.81	-1.29	-12	-9.10	-3.63	9.09	-3.69	-0.46	5.79	4.41	15
Net Income / (Loss) Continuing Operations	-12	-11	-17	-14	-10	-9.90	-15	-26	-12	-8.64	-5.26
Consolidated Net Income / (Loss)	-12	-11	-17	-14	-10	-9.90	-15	-26	-12	-8.64	-5.26
Depreciation Expense	2.48	2.80	3.15	3.26	3.21	3.39	4.25	4.50	5.00	5.01	4.93
Amortization Expense	-12	0.46	0.46	0.47	0.46	0.47	0.47	0.47	0.59	0.57	0.57
Non-Cash Adjustments To Reconcile Net Income	20	7.42	7.38	9.58	8.44	10	8.84	26	13	13	9.62
Changes in Operating Assets and Liabilities, net	-4.31	-1.42	-6.13	-8.70	-5.55	5.01	-2.16	-5.01	-1.05	-5.44	4.76
Net Cash From Investing Activities	-6.56	11	2.93	-15	-2.59	-5.45	-3.69	-0.15	-2.15	-11	-9.32
Net Cash From Continuing Investing Activities	-6.56	11	2.93	-15	-2.59	-5.45	-3.69	-0.15	-2.15	-11	-9.32
Purchase of Property, Plant & Equipment	-3.57	-6.42	-4.35	-4.40	-4.81	-4.54	-5.50	-6.96	-7.45	-10	-11
Purchase of Investments	-2.99	-2.95	-2.73	-11	-2.77	-2.50	-2.27	-2.17	-2.13	-1.97	-12
Sale and/or Maturity of Investments	-	20	10	0.01	4.99	1.59	4.08	8.98	7.43	1.59	14
Net Cash From Financing Activities	0.28	-0.36	1.23	0.56	1.42	1.42	0.51	1.54	0.46	0.38	0.83
Net Cash From Continuing Financing Activities	0.28	-0.36	1.23	0.56	1.42	1.42	0.51	1.54	0.46	0.38	0.83
Other Financing Activities, net	0.28	-0.36	1.23	0.56	1.42	1.42	0.51	-17	1.29	0.38	0.83
Effect of Exchange Rate Changes	-0.11	0.08	-0.15	-0.02	0.17	-0.26	0.14	0.28	-0.01	0.01	-0.08
Cash Interest Paid	1.44	-	1.44	-	1.44	-	1.44	0.73	0.43	0.95	0.43
Cash Income Taxes Paid	-	-	-	-	-	-	0.00	-	-	-	0.23

This table presents Xometry's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	89	503	734	707	680	704
Total Current Assets	78	163	387	356	328	335
Cash & Equivalents	60	86	66	53	22	15
Short-Term Investments	0.00	30	254	215	218	204
Accounts Receivable	15	32	49	70	74	97
Inventories, net	2.29	2.03	1.57	2.89	3.92	3.92
Prepaid Expenses	0.91	6.66	7.59	5.57	4.95	7.26
Other Current Assets	0.00	5.58	9.37	8.90	4.87	6.95
Plant, Property, & Equipment, net	6.11	10	19	36	45	61
Total Noncurrent Assets	5.20	329	328	316	308	308
Long-Term Investments	0.00	4.20	4.07	4.11	4.07	4.07
Goodwill	0.83	255	258	263	263	264
Intangible Assets	1.65	42	39	36	32	29
Other Noncurrent Operating Assets	2.71	28	26	13	8.87	12
Total Liabilities & Shareholders' Equity	89	503	734	707	680	704
Total Liabilities	39	77	362	377	365	427
Total Current Liabilities	38	57	64	83	75	89
Short-Term Debt	16	-	-	-	-	0.00
Accounts Payable	5.64	13	12	44	35	45
Accrued Expenses	14	31	33	23	24	32
Current Deferred Revenue	-	7.86	8.73	-	7.95	10
Current Deferred & Payable Income Tax Liabilities	-	0.00	3.96	2.48	0.98	0.27
Other Current Liabilities	3.38	5.55	5.47	14	6.44	2.07
Total Noncurrent Liabilities	1.12	20	298	294	290	338
Long-Term Debt	-	0.00	280	282	284	328
Noncurrent Deferred & Payable Income Tax Liabilities	-	0.02	0.43	0.28	0.23	0.15
Other Noncurrent Operating Liabilities	1.12	19	18	12	5.89	10
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-111	425	372	330	316	277
Total Preferred & Common Equity	-111	424	371	329	314	276
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-111	424	371	329	314	276
Common Stock	0.50	598	623	648	685	711
Retained Earnings	-112	-173	-252	-320	-370	-432
Treasury Stock	-	-	-	-	0.00	-8.08
Accumulated Other Comprehensive Income / (Loss)	0.21	0.15	0.03	0.86	-0.33	4.77
Noncontrolling Interest	0.00	1.03	1.09	1.12	1.14	1.14

This table presents Xometry's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	754	725	708	701	692	679	678	690	687	699	740
Total Current Assets	410	373	365	357	341	327	326	335	329	341	364
Cash & Equivalents	30	40	57	44	46	22	17	16	17	21	21
Short-Term Investments	311	256	229	232	208	219	217	216	209	204	203
Accounts Receivable	51	52	58	64	69	71	79	86	87	99	120
Inventories, net	5.63	1.44	1.34	1.31	2.89	2.87	3.50	4.03	4.63	4.24	3.60
Prepaid Expenses	7.68	7.06	5.83	4.90	6.00	6.06	4.79	6.49	5.12	5.90	7.04
Other Current Assets	4.36	16	14	10	9.37	6.51	4.86	7.19	6.09	7.55	9.70
Plant, Property, & Equipment, net	16	22	24	26	38	40	42	47	51	55	69
Total Noncurrent Assets	328	330	320	318	314	312	310	308	307	303	307
Long-Term Investments	4.30	4.13	4.27	4.21	4.21	4.14	4.21	4.07	4.09	4.21	4.12
Goodwill	260	262	263	263	263	263	263	263	264	264	264
Intangible Assets	40	39	38	37	35	34	33	31	30	29	28
Other Noncurrent Operating Assets	24	25	15	14	12	11	9.98	9.92	9.13	5.79	12
Total Liabilities & Shareholders' Equity	754	725	708	701	692	679	678	690	687	699	740
Total Liabilities	361	362	366	364	371	362	362	379	416	426	457
Total Current Liabilities	65	65	69	68	79	71	71	89	84	94	204
Short-Term Debt	-	-	-	-	-	-	-	-	-	-	85
Accounts Payable	12	12	13	13	14	10	6.37	50	42	46	62
Accrued Expenses	36	32	37	35	46	43	49	23	27	33	42
Current Deferred Revenue	11	9.97	10.00	9.66	9.61	9.05	8.30	9.91	10	11	12
Current Deferred & Payable Income Tax Liabilities	-	4.11	2.80	2.96	2.21	1.33	0.86	0.89	0.87	0.73	0.28
Other Current Liabilities	5.90	6.26	6.50	6.74	6.73	6.66	6.64	5.29	4.18	2.55	2.40
Total Noncurrent Liabilities	296	298	297	296	292	291	291	290	331	332	253
Long-Term Debt	279	280	281	281	282	283	283	284	326	327	243
Noncurrent Deferred & Payable Income Tax Liabilities	-	0.41	0.39	0.36	0.28	0.26	0.25	0.23	0.21	0.19	0.15
Other Noncurrent Operating Liabilities	15	17	16	14	9.63	8.17	7.55	5.33	4.90	4.51	9.80
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	393	362	342	337	322	317	316	311	272	273	283
Total Preferred & Common Equity	392	361	341	336	320	316	315	310	270	272	282
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	392	361	341	336	320	316	315	310	270	272	282
Common Stock	617	629	635	642	657	666	674	694	686	699	723
Retained Earnings	-225	-268	-294	-306	-336	-350	-360	-385	-412	-423	-437
Treasury Stock	-	-	-	-	-	-	-	-	-8.08	-8.08	-8.08
Accumulated Other Comprehensive Income / (Loss)	-0.49	0.16	0.36	0.44	0.38	0.46	1.28	1.21	4.28	4.45	4.08
Noncontrolling Interest	1.12	1.10	1.11	1.14	1.15	1.15	1.13	1.13	1.12	1.13	1.15

This table displays calculated financial ratios and metrics derived from Xometry's official financial filings.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-
Revenue Growth	0.00%	76.26%	54.40%	74.47%	21.65%	17.72%	25.87%
EBITDA Growth	0.00%	7.14%	-115.64%	-20.33%	10.39%	32.73%	-5.57%
EBIT Growth	0.00%	2.46%	-105.20%	-28.79%	5.28%	24.21%	-14.62%
NOPAT Growth	0.00%	4.36%	-100.87%	-31.36%	4.56%	23.69%	18.94%
Net Income Growth	0.00%	-0.29%	-97.46%	-28.77%	14.65%	25.29%	-22.51%
EPS Growth	0.00%	-9.02%	12.41%	27.90%	16.07%	26.95%	-18.45%
Operating Cash Flow Growth	0.00%	18.71%	-210.99%	8.74%	52.25%	48.51%	139.56%
Free Cash Flow Firm Growth	0.00%	0.00%	-1,219.27%	77.19%	19.35%	11.60%	-4.06%
Invested Capital Growth	0.00%	0.00%	5,600.13%	7.77%	3.38%	4.72%	7.24%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	8.85%	6.94%	3.89%	6.82%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	-3.09%	19.96%	5.13%	8.90%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	-4.44%	16.55%	2.87%	3.85%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	-6.59%	16.75%	1.78%	5.69%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	-4.71%	20.04%	1.29%	2.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	-27.27%	18.02%	16.60%	46.49%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-62.21%	18.43%	34.55%	40.29%	-43.43%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	13.27%	13.65%	-31.43%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.40%	0.62%	-1.65%	2.62%
Profitability Metrics	-	-	-	-	-	-	-
Gross Margin	18.37%	23.54%	26.17%	38.33%	38.47%	39.53%	39.14%
EBITDA Margin	-36.08%	-19.01%	-26.54%	-18.31%	-13.48%	-7.71%	-6.46%
Operating Margin	-38.08%	-20.66%	-26.88%	-20.24%	-15.88%	-10.29%	-6.63%
EBIT Margin	-38.33%	-21.21%	-28.19%	-20.81%	-16.20%	-10.43%	-9.50%
Profit (Net Income) Margin	-38.63%	-21.98%	-28.11%	-20.75%	-14.56%	-9.24%	-8.99%
Tax Burden Percent	100.00%	100.00%	100.00%	100.05%	99.48%	99.96%	100.96%
Interest Burden Percent	100.78%	103.63%	99.72%	99.66%	90.32%	88.61%	93.77%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-765.53%	-26.51%	-17.06%	-15.43%	-11.32%	-8.65%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-717.33%	-1.91%	13.43%	76.54%	-56.98%	-50.15%
Return on Net Nonoperating Assets (RNNOA)	0.00%	639.85%	0.66%	-2.77%	-3.78%	-4.29%	-12.20%
Return on Equity (ROE)	0.00%	-125.69%	-25.85%	-19.83%	-19.21%	-15.60%	-20.85%
Cash Return on Invested Capital (CROIC)	0.00%	-965.53%	-219.62%	-24.53%	-18.75%	-15.93%	-15.64%
Operating Return on Assets (OROA)	0.00%	-33.72%	-20.81%	-12.82%	-10.42%	-8.20%	-9.43%
Return on Assets (ROA)	0.00%	-34.94%	-20.75%	-12.78%	-9.36%	-7.27%	-8.92%
Return on Common Equity (ROCE)	0.00%	282.68%	-17.04%	-19.78%	-19.15%	-15.55%	-20.77%
Return on Equity Simple (ROE_SIMPLE)	0.00%	27.94%	-14.46%	-21.32%	-20.49%	-16.03%	0.00%
Net Operating Profit after Tax (NOPAT)	-21	-20	-41	-54	-52	-39	-32
NOPAT Margin	-26.65%	-14.46%	-18.82%	-14.17%	-11.11%	-7.20%	-4.64%
Net Nonoperating Expense Percent (NNEP)	0.00%	-48.20%	-24.60%	-30.49%	-91.97%	45.67%	41.50%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-8.28%	-8.41%	-6.56%	-5.27%
Cost of Revenue to Revenue	81.63%	76.46%	73.83%	61.67%	61.53%	60.47%	60.86%
SG&A Expenses to Revenue	9.99%	8.52%	16.00%	15.29%	15.30%	11.91%	10.53%
R&D to Revenue	13.26%	8.62%	8.14%	8.14%	7.44%	7.21%	6.81%
Operating Expenses to Revenue	56.45%	44.20%	53.05%	58.56%	54.34%	49.82%	45.77%
Earnings before Interest and Taxes (EBIT)	-31	-30	-62	-79	-75	-57	-65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-29	-27	-58	-70	-62	-42	-44
Valuation Ratios	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	5.04	3.89	4.95	6.72	11.06
Price to Tangible Book Value (P/TBV)	0.00	0.00	16.71	19.68	53.24	107.72	0.00
Price to Revenue (P/Rev)	3.77	2.14	9.80	3.79	3.52	3.88	4.44
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	78.44	6.63	4.27	4.83	6.07	8.28
Enterprise Value to Revenue (EV/Rev)	0.00	2.96	9.25	3.68	3.54	3.95	4.59
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	518.10
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-
Debt to Equity	0.00	0.32	0.00	0.75	0.85	0.90	1.18
Long-Term Debt to Equity	0.00	0.00	0.00	0.75	0.85	0.90	1.18
Financial Leverage	0.00	-0.89	-0.35	-0.21	-0.05	0.08	0.24
Leverage Ratio	0.00	1.80	1.25	1.55	2.05	2.15	2.34
Compound Leverage Factor	0.00	1.86	1.24	1.55	1.85	1.90	2.19
Debt to Total Capital	0.00%	24.15%	0.00%	42.95%	46.03%	47.33%	54.20%
Short-Term Debt to Total Capital	0.00%	24.15%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	42.95%	46.03%	47.33%	54.20%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	246.43%	0.24%	0.17%	0.18%	0.19%	0.19%
Common Equity to Total Capital	0.00%	-170.58%	99.76%	56.88%	53.79%	52.48%	45.61%
Debt to EBITDA	0.00	-0.59	0.00	-4.01	-4.51	-6.75	-7.38
Net Debt to EBITDA	0.00	1.64	0.00	0.63	-0.14	-0.95	-2.35
Long-Term Debt to EBITDA	0.00	0.00	0.00	-4.01	-4.51	-6.75	-7.38
Debt to NOPAT	0.00	-0.77	0.00	-5.19	-5.47	-7.22	-10.28
Net Debt to NOPAT	0.00	2.16	0.00	0.81	-0.17	-1.01	-3.27
Long-Term Debt to NOPAT	0.00	0.00	0.00	-5.19	-5.47	-7.22	-10.28
Altman Z-Score	0.00	3.84	16.45	2.60	2.73	3.69	4.51
Noncontrolling Interest Sharing Ratio	0.00%	324.91%	34.06%	0.27%	0.31%	0.35%	0.38%
Liquidity Ratios	-	-	-	-	-	-	-
Current Ratio	0.00	2.02	2.87	6.05	4.28	4.38	3.76
Quick Ratio	0.00	1.94	2.62	5.76	4.07	4.20	3.56
Cash Flow Metrics	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-26	-340	-78	-63	-55	-58
Operating Cash Flow to CapEx	-1,068.75%	-526.23%	-1,095.03%	-464.86%	-163.59%	-85.38%	20.17%
Free Cash Flow to Firm to Interest Expense	0.00	-23.69	-399.41	-17.57	-13.08	-11.64	-11.73
Operating Cash Flow to Interest Expense	-112.55	-20.25	-80.48	-14.16	-6.25	-3.24	1.24
Operating Cash Flow Less CapEx to Interest Expense	-123.08	-24.09	-87.83	-17.21	-10.06	-7.03	-4.91
Efficiency Ratios	-	-	-	-	-	-	-
Asset Turnover	0.00	1.59	0.74	0.62	0.64	0.79	0.99
Accounts Receivable Turnover	0.00	9.70	9.29	9.32	7.76	7.57	8.02
Inventory Turnover	0.00	47.13	74.51	130.37	127.98	97.03	106.71
Fixed Asset Turnover	0.00	23.13	26.63	25.94	16.94	13.56	13.02
Accounts Payable Turnover	0.00	19.17	17.56	18.68	10.13	8.36	10.49
Days Sales Outstanding (DSO)	0.00	37.62	39.29	39.14	47.01	48.19	45.54
Days Inventory Outstanding (DIO)	0.00	7.74	4.90	2.80	2.85	3.76	3.42
Days Payable Outstanding (DPO)	0.00	19.04	20.78	19.54	36.04	43.65	34.78
Cash Conversion Cycle (CCC)	0.00	26.32	23.40	22.40	13.82	8.31	14.18
Capital & Investment Metrics	-	-	-	-	-	-	-
Invested Capital	0.00	5.34	305	328	339	355	381
Invested Capital Turnover	0.00	52.93	1.41	1.20	1.39	1.57	1.86
Increase / (Decrease) in Invested Capital	0.00	5.34	299	24	11	16	26
Enterprise Value (EV)	0.00	419	2,020	1,400	1,640	2,155	3,153
Market Capitalization	303	303	2,139	1,443	1,630	2,114	3,048
Book Value per Share	$0.00	($14.85)	$10.17	$8.28	$7.25	$6.34	$5.38
Tangible Book Value per Share	$0.00	($15.18)	$3.07	$1.64	$0.67	$0.40	($0.33)
Total Capital	0.00	65	425	652	612	599	604
Total Debt	0.00	16	0.00	280	282	284	328
Total Long-Term Debt	0.00	0.00	0.00	280	282	284	328
Net Debt	0.00	-44	-121	-44	8.88	40	104
Capital Expenditures (CapEx)	2.54	4.19	6.26	13	18	18	30
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-4.85	-10	3.79	4.26	13	27
Debt-free Net Working Capital (DFNWC)	0.00	55	106	323	273	253	246
Net Working Capital (NWC)	0.00	39	106	323	273	253	246
Net Nonoperating Expense (NNE)	9.61	11	20	25	16	11	30
Net Nonoperating Obligations (NNO)	0.00	-44	-121	-44	8.88	40	104
Total Depreciation and Amortization (D&A)	1.81	3.12	3.60	9.54	13	15	21
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-3.43%	-4.73%	0.99%	0.92%	2.37%	3.87%
Debt-free Net Working Capital to Revenue	0.00%	38.91%	48.73%	84.85%	58.92%	46.33%	35.78%
Net Working Capital to Revenue	0.00%	27.77%	48.73%	84.85%	58.92%	46.33%	35.78%
Earnings Adjustments	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($2.33)	($1.61)	($2.82)	($2.06)	($1.22)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	44.16M	47.16M	95.83M	98.17M	50.81M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($2.33)	($1.61)	($2.82)	($2.06)	($1.22)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	44.16M	47.16M	95.83M	98.17M	50.81M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	($2.33)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	26.32M	45.07M	48.58M	50.30M	51.82M
Normalized Net Operating Profit after Tax (NOPAT)	-20	-19	-41	-53	-51	-39	-32
Normalized NOPAT Margin	-25.15%	-13.67%	-18.82%	-14.02%	-11.05%	-7.19%	-4.64%
Pre Tax Income Margin	-38.63%	-21.98%	-28.11%	-20.74%	-14.63%	-9.24%	-8.91%
Debt Service Ratios	-	-	-	-	-	-	-
EBIT to Interest Expense	-127.61	-27.54	-72.24	-17.94	-15.70	-11.98	-13.29
NOPAT to Interest Expense	-88.73	-18.78	-48.22	-12.21	-10.77	-8.27	-6.49
EBIT Less CapEx to Interest Expense	-138.14	-31.39	-79.59	-20.99	-19.51	-15.77	-19.44
NOPAT Less CapEx to Interest Expense	-99.26	-22.63	-55.57	-15.26	-14.58	-12.06	-12.64
Payout Ratios	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	-28.31%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-28.31%	-5.99%	0.00%	0.00%	0.00%	-13.09%

This table displays calculated financial ratios and metrics derived from Xometry's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	51,824,424.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	51,824,424.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-0.10
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	14.83%	30.67%	16.49%	19.45%	19.15%	15.92%	23.05%	22.59%	27.54%	29.52%	35.88%
EBITDA Growth	-75.66%	61.81%	12.61%	9.86%	64.18%	23.58%	20.97%	-92.27%	13.86%	58.93%	98.43%
EBIT Growth	10.94%	53.60%	7.72%	45.78%	13.55%	13.02%	10.81%	-78.17%	-6.46%	23.29%	65.07%
NOPAT Growth	13.17%	54.13%	9.75%	45.50%	13.00%	8.11%	13.81%	32.70%	3.68%	23.83%	66.08%
Net Income Growth	20.15%	61.57%	9.48%	48.40%	15.08%	6.23%	9.20%	-92.91%	-13.71%	12.71%	65.12%
EPS Growth	21.88%	27.43%	10.53%	49.09%	16.00%	25.00%	11.76%	-85.71%	-9.52%	15.00%	66.67%
Operating Cash Flow Growth	47.18%	92.42%	28.69%	-47.94%	39.19%	802.09%	68.54%	95.31%	259.38%	-51.44%	496.18%
Free Cash Flow Firm Growth	93.91%	53.57%	60.70%	1.42%	-64.18%	-21.26%	-54.69%	36.51%	44.65%	-32.25%	-10.32%
Invested Capital Growth	3.15%	3.38%	1.00%	6.53%	7.13%	4.72%	4.00%	3.78%	2.77%	7.24%	6.53%
Revenue Q/Q Growth	7.13%	7.75%	-4.26%	8.07%	6.87%	4.83%	1.63%	7.67%	11.18%	6.46%	6.62%
EBITDA Q/Q Growth	-75.91%	58.18%	-51.87%	19.33%	30.10%	10.77%	-57.07%	-96.26%	68.68%	57.45%	93.98%
EBIT Q/Q Growth	51.82%	6.52%	-41.49%	14.92%	23.17%	5.95%	-45.08%	-69.97%	54.10%	32.23%	33.93%
NOPAT Q/Q Growth	52.96%	4.99%	-42.41%	14.38%	24.91%	-0.36%	-33.58%	33.14%	-7.47%	20.64%	40.52%
Net Income Q/Q Growth	54.78%	12.13%	-57.34%	17.47%	25.58%	2.97%	-52.34%	-75.36%	56.13%	25.52%	39.12%
EPS Q/Q Growth	54.55%	-556.00%	79.27%	17.65%	25.00%	-485.71%	75.61%	-73.33%	55.77%	26.09%	41.18%
Operating Cash Flow Q/Q Growth	2.86%	78.35%	-806.80%	22.44%	60.07%	350.00%	-140.63%	88.43%	1,456.44%	-23.83%	231.44%
Free Cash Flow Firm Q/Q Growth	40.60%	-1.63%	19.92%	-103.92%	1.07%	24.93%	-2.15%	16.30%	13.75%	-79.34%	14.79%
Invested Capital Q/Q Growth	1.30%	0.62%	1.93%	2.54%	1.87%	-1.65%	1.22%	2.32%	0.89%	2.62%	0.56%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	38.89%	38.30%	39.04%	39.88%	39.40%	39.73%	37.31%	40.10%	39.86%	39.10%	38.26%
EBITDA Margin	-19.36%	-7.52%	-11.92%	-8.90%	-5.82%	-4.95%	-7.66%	-13.96%	-3.93%	-1.57%	-0.09%
Operating Margin	-11.10%	-9.79%	-14.55%	-11.53%	-8.10%	-7.76%	-10.19%	-6.33%	-6.12%	-4.56%	-2.54%
EBIT Margin	-11.60%	-10.06%	-14.87%	-11.71%	-8.42%	-7.55%	-10.78%	-17.01%	-7.02%	-4.47%	-2.77%
Profit (Net Income) Margin	-10.10%	-8.24%	-13.53%	-10.34%	-7.20%	-6.66%	-9.99%	-16.26%	-6.42%	-4.49%	-2.56%
Tax Burden Percent	101.17%	94.95%	100.00%	99.93%	100.30%	99.59%	100.00%	99.97%	99.85%	107.65%	104.95%
Interest Burden Percent	86.06%	86.20%	91.01%	88.35%	85.27%	88.60%	92.66%	95.62%	91.48%	93.27%	88.16%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-10.14%	-9.51%	-14.23%	-11.80%	-8.53%	-8.53%	-11.61%	-7.40%	-7.52%	-5.95%	-3.55%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.70%	0.72%	-204.15%	-33.18%	-18.09%	-16.06%	-23.41%	-36.08%	-12.90%	-9.42%	-5.71%
Return on Net Nonoperating Assets (RNNOA)	0.15%	-0.04%	-1.29%	-1.41%	-1.25%	-1.21%	-2.70%	-8.22%	-3.13%	-2.29%	-1.43%
Return on Equity (ROE)	-9.98%	-9.55%	-15.52%	-13.21%	-9.78%	-9.74%	-14.31%	-15.63%	-10.65%	-8.24%	-4.98%
Cash Return on Invested Capital (CROIC)	-21.73%	-18.75%	-15.56%	-18.31%	-18.35%	-15.93%	-14.57%	-13.14%	-11.96%	-15.64%	-12.99%
Operating Return on Assets (OROA)	-6.91%	-6.47%	-10.09%	-8.48%	-6.41%	-5.94%	-8.95%	-15.04%	-6.56%	-4.44%	-2.87%
Return on Assets (ROA)	-6.02%	-5.29%	-9.18%	-7.49%	-5.48%	-5.24%	-8.29%	-14.38%	-5.99%	-4.46%	-2.66%
Return on Common Equity (ROCE)	-9.95%	-9.52%	-15.47%	-13.16%	-9.75%	-9.70%	-14.25%	-15.57%	-10.61%	-8.21%	-4.96%
Return on Equity Simple (ROE_SIMPLE)	-25.13%	0.00%	-20.51%	-16.74%	-16.20%	0.00%	-15.77%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-9.24	-8.78	-12	-11	-8.04	-8.07	-11	-7.20	-7.74	-6.14	-3.65
NOPAT Margin	-7.77%	-6.85%	-10.19%	-8.07%	-5.67%	-5.43%	-7.14%	-4.43%	-4.28%	-3.19%	-1.78%
Net Nonoperating Expense Percent (NNEP)	-8.44%	-10.23%	189.92%	21.39%	9.56%	7.53%	11.81%	28.67%	5.39%	3.46%	2.16%
Return On Investment Capital (ROIC_SIMPLE)	-	-1.43%	-	-	-	-1.35%	-1.81%	-1.20%	-1.29%	-1.02%	-0.60%
Cost of Revenue to Revenue	61.11%	61.70%	60.96%	60.12%	60.60%	60.27%	62.69%	59.90%	60.14%	60.90%	61.74%
SG&A Expenses to Revenue	12.56%	11.27%	12.16%	12.43%	11.33%	11.77%	11.28%	10.42%	10.77%	9.80%	10.07%
R&D to Revenue	7.17%	6.94%	7.82%	7.56%	6.59%	6.98%	7.40%	6.77%	6.93%	6.28%	5.57%
Operating Expenses to Revenue	49.99%	48.09%	53.60%	51.41%	47.50%	47.49%	47.51%	46.43%	45.98%	43.67%	40.81%
Earnings before Interest and Taxes (EBIT)	-14	-13	-18	-16	-12	-11	-16	-28	-13	-8.60	-5.68
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-23	-9.63	-15	-12	-8.25	-7.36	-12	-23	-7.11	-3.02	-0.18
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.29	4.95	2.56	1.69	2.87	6.72	4.04	6.33	10.17	11.06	7.50
Price to Tangible Book Value (P/TBV)	21.25	53.24	36.04	27.93	47.07	107.72	80.11	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.77	3.52	1.71	1.06	1.72	3.88	2.18	2.84	4.30	4.44	2.86
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.28	4.83	2.45	1.61	2.63	6.07	3.62	4.92	7.72	8.28	5.79
Enterprise Value to Revenue (EV/Rev)	1.78	3.54	1.76	1.14	1.81	3.95	2.27	3.00	4.46	4.59	2.99
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1,357.83	266.40	518.10	90.89
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.84	0.85	0.88	0.89	0.90	0.90	0.91	1.20	1.20	1.18	1.16
Long-Term Debt to Equity	0.84	0.85	0.88	0.89	0.90	0.90	0.91	1.20	1.20	1.18	0.86
Financial Leverage	-0.09	-0.05	0.01	0.04	0.07	0.08	0.12	0.23	0.24	0.24	0.25
Leverage Ratio	1.99	2.05	2.07	2.10	2.11	2.15	2.19	2.32	2.34	2.34	2.41
Compound Leverage Factor	1.72	1.77	1.89	1.86	1.80	1.90	2.02	2.22	2.14	2.18	2.12
Debt to Total Capital	45.50%	46.03%	46.74%	47.14%	47.23%	47.33%	47.74%	54.59%	54.49%	54.20%	53.67%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	13.96%
Long-Term Debt to Total Capital	45.50%	46.03%	46.74%	47.14%	47.23%	47.33%	47.74%	54.59%	54.49%	54.20%	39.71%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.18%	0.18%	0.19%	0.19%	0.19%	0.19%	0.19%	0.19%	0.19%	0.19%	0.19%
Common Equity to Total Capital	54.31%	53.79%	53.07%	52.67%	52.58%	52.48%	52.07%	45.22%	45.32%	45.61%	46.14%
Debt to EBITDA	-3.60	-4.51	-4.67	-4.78	-6.39	-6.75	-7.29	-6.55	-6.71	-7.38	-9.94
Net Debt to EBITDA	0.00	-0.14	-0.40	-0.64	-1.01	-0.95	-1.25	-1.94	-2.02	-2.35	-3.03
Long-Term Debt to EBITDA	-3.60	-4.51	-4.67	-4.78	-6.39	-6.75	-7.29	-6.55	-6.71	-7.38	-7.36
Debt to NOPAT	-4.55	-5.47	-5.63	-6.86	-7.08	-7.22	-7.56	-9.58	-9.68	-10.28	-13.26
Net Debt to NOPAT	-0.01	-0.17	-0.48	-0.91	-1.12	-1.01	-1.29	-2.83	-2.91	-3.27	-4.04
Long-Term Debt to NOPAT	-4.55	-5.47	-5.63	-6.86	-7.08	-7.22	-7.56	-9.58	-9.68	-10.28	-9.81
Altman Z-Score	1.71	3.02	1.71	1.28	1.92	3.91	2.38	2.81	4.33	4.78	3.19
Noncontrolling Interest Sharing Ratio	0.31%	0.31%	0.33%	0.34%	0.35%	0.35%	0.36%	0.39%	0.38%	0.38%	0.38%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.27	4.28	4.34	4.64	4.59	4.38	3.74	3.91	3.62	3.76	1.78
Quick Ratio	5.03	4.07	4.10	4.42	4.41	4.20	3.54	3.72	3.44	3.56	1.68
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-20	-20	-16	-32	-32	-24	-25	-21	-18	-32	-27
Operating Cash Flow to CapEx	-167.35%	-20.15%	-269.93%	-210.48%	-75.55%	200.24%	-67.12%	-6.13%	77.76%	42.96%	138.20%
Free Cash Flow to Firm to Interest Expense	-16.22	-16.72	-13.38	-27.31	-27.04	-20.28	-20.71	-17.43	-13.90	-25.31	-21.58
Operating Cash Flow to Interest Expense	-4.96	-1.09	-9.87	-7.66	-3.06	7.65	-3.11	-0.36	4.53	3.50	11.62
Operating Cash Flow Less CapEx to Interest Expense	-7.92	-6.50	-13.52	-11.30	-7.11	3.83	-7.74	-6.25	-1.30	-4.65	3.21
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.60	0.64	0.68	0.72	0.76	0.79	0.83	0.88	0.93	0.99	1.04
Accounts Receivable Turnover	7.55	7.76	7.91	7.81	7.37	7.57	7.41	7.65	7.25	8.02	7.22
Inventory Turnover	77.71	127.98	135.66	145.48	132.85	97.03	101.06	97.91	100.82	106.71	117.89
Fixed Asset Turnover	20.64	16.94	16.25	15.79	15.44	13.56	13.53	13.29	13.27	13.02	12.73
Accounts Payable Turnover	21.24	10.13	22.35	26.82	32.44	8.36	10.89	14.07	14.83	10.49	8.00
Days Sales Outstanding (DSO)	48.38	47.01	46.14	46.76	49.53	48.19	49.25	47.74	50.37	45.54	50.57
Days Inventory Outstanding (DIO)	4.70	2.85	2.69	2.51	2.75	3.76	3.61	3.73	3.62	3.42	3.10
Days Payable Outstanding (DPO)	17.19	36.04	16.33	13.61	11.25	43.65	33.50	25.94	24.60	34.78	45.63
Cash Conversion Cycle (CCC)	35.88	13.82	32.49	35.66	41.02	8.31	19.36	25.53	29.39	14.18	8.03
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	337	339	346	355	361	355	360	368	371	381	383
Invested Capital Turnover	1.30	1.39	1.40	1.46	1.50	1.57	1.63	1.67	1.75	1.86	1.99
Increase / (Decrease) in Invested Capital	10	11	3.41	22	24	16	14	13	10	26	23
Enterprise Value (EV)	771	1,640	846	572	952	2,155	1,303	1,810	2,866	3,153	2,218
Market Capitalization	769	1,630	820	533	906	2,114	1,254	1,712	2,767	3,048	2,117
Book Value per Share	$7.41	$7.25	$6.60	$6.85	$6.39	$6.34	$6.16	$5.34	$5.35	$5.38	$5.44
Tangible Book Value per Share	$0.80	$0.67	$0.47	$0.41	$0.39	$0.40	$0.31	($0.47)	($0.42)	($0.33)	($0.18)
Total Capital	618	612	604	600	600	599	595	598	600	604	611
Total Debt	281	282	282	283	283	284	284	326	327	328	328
Total Long-Term Debt	281	282	282	283	283	284	284	326	327	328	243
Net Debt	0.33	8.88	24	38	45	40	49	97	98	104	100
Capital Expenditures (CapEx)	3.57	6.42	4.35	4.32	4.81	4.54	5.50	6.96	7.45	10	11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	13	4.26	8.84	16	21	13	14	19	22	27	21
Debt-free Net Working Capital (DFNWC)	289	273	263	257	255	253	245	244	247	246	245
Net Working Capital (NWC)	289	273	263	257	255	253	245	244	247	246	160
Net Nonoperating Expense (NNE)	2.77	1.78	4.10	3.00	2.16	1.83	4.30	19	3.86	2.49	1.61
Net Nonoperating Obligations (NNO)	0.33	8.88	24	38	45	40	49	97	98	104	100
Total Depreciation and Amortization (D&A)	-9.24	3.26	3.62	3.72	3.68	3.86	4.71	4.97	5.59	5.58	5.50
Debt-free, Cash-free Net Working Capital to Revenue	2.93%	0.92%	1.84%	3.18%	3.96%	2.37%	2.41%	3.10%	3.49%	3.87%	2.84%
Debt-free Net Working Capital to Revenue	66.80%	58.92%	54.63%	51.14%	48.52%	46.33%	42.73%	40.49%	38.42%	35.78%	33.07%
Net Working Capital to Revenue	66.80%	58.92%	54.63%	51.14%	48.52%	46.33%	42.73%	40.49%	38.42%	35.78%	21.55%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.25)	($1.64)	($0.34)	($0.28)	($0.21)	($1.23)	($0.30)	($0.52)	($0.23)	($0.17)	($0.10)
Adjusted Weighted Average Basic Shares Outstanding	47.99M	95.83M	48.58M	48.84M	49.28M	98.17M	50.34M	50.70M	50.92M	50.81M	51.91M
Adjusted Diluted Earnings per Share	($0.25)	($1.64)	($0.34)	($0.28)	($0.21)	($1.23)	($0.30)	($0.52)	($0.23)	($0.17)	($0.10)
Adjusted Weighted Average Diluted Shares Outstanding	47.99M	95.83M	48.58M	48.84M	49.28M	98.17M	50.34M	50.70M	50.92M	50.81M	51.91M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	45.39M	48.58M	46.12M	49.30M	49.56M	50.30M	50.68M	50.80M	51.25M	51.82M	52.60M
Normalized Net Operating Profit after Tax (NOPAT)	-9.13	-8.78	-12	-11	-8.04	-8.01	-11	-7.20	-7.71	-6.14	-3.65
Normalized NOPAT Margin	-7.68%	-6.85%	-10.19%	-8.07%	-5.67%	-5.39%	-7.14%	-4.43%	-4.26%	-3.19%	-1.78%
Pre Tax Income Margin	-9.98%	-8.67%	-13.53%	-10.34%	-7.18%	-6.69%	-9.99%	-16.27%	-6.43%	-4.17%	-2.44%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-11.45	-10.85	-15.34	-13.07	-10.05	-9.44	-13.70	-23.40	-9.93	-6.83	-4.52
NOPAT to Interest Expense	-7.67	-7.39	-10.51	-9.01	-6.77	-6.79	-9.07	-6.09	-6.06	-4.88	-2.90
EBIT Less CapEx to Interest Expense	-14.41	-16.26	-19.00	-16.71	-14.10	-13.26	-18.32	-29.29	-15.76	-14.99	-12.93
NOPAT Less CapEx to Interest Expense	-10.63	-12.79	-14.17	-12.65	-10.82	-10.61	-13.70	-11.98	-11.89	-13.04	-11.32
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-13.12%	-12.82%	-13.09%	0.00%

Financials Breakdown Chart

Key Financial Trends

Here are the key, investor-focused takeaways for Xometry (XMTR) based on the last four years of quarterly statements. Items are grouped from most to least likely to positively impact the stock, then neutral, then negative.

Revenue growth steady over the period. Operating revenue rose from about $98 million in 2022 Q4 to roughly $192 million in 2025 Q4, indicating consistent top‑line expansion.
Net loss narrowed in 2025, signaling improving profitability on the bottom line. Net income to common shareholders eased to about −$8.64 million in 2025 Q4, an improvement versus the deeper losses seen earlier in 2023–2024.
Positive operating cash flow in the latest quarter. 2025 Q4 cash flow from continuing operating activities was about $4.41 million, marking a positive cash generation point after several negative quarters.
Gross margin remains stable around the high 30s to 40% range. Total gross profit as a share of revenue has consistently hovered around 39–40% across recent years, indicating consistent gross profitability.
Capex remains moderate and steady. Purchases of property, plant & equipment run in the mid to high single-digit millions per quarter (e.g., around $5–$11 million quarterly, with quarterly swings), suggesting ongoing but manageable investment in fixed assets.
Debt level is relatively stable with a modest cash balance. Long‑term debt sits around $326–327 million in recent quarters, while cash and equivalents run around $21 million, implying a balanced liquidity/d leverage profile without sharp near-term refinancing pressure.
Balance sheet size shows a stable asset base and equity slice. Total assets sit near $690–700 million and total equity roughly in the low to mid $270 millions, indicating a steady, albeit growing, balance sheet footprint over the period.
Persistent quarterly net losses continue to weigh on fundamentals. Net income remains negative in most quarters across 2022–2025, underscoring ongoing profitability challenges.
Cash burn observed in several periods. While Q4 2025 turned positive on operating cash flow, multiple prior quarters showed negative net cash from operating activities, pointing to continued cash burn at times.
High goodwill and intangible asset levels may indicate impairment risk if growth slows. Goodwill and other noncurrent assets are sizable relative to equity in several periods, which could pose impairment risk if operating performance deteriorates.

05/20/26 01:48 AM ETAI Generated. May Contain Errors.

Xometry Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Xometry's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Xometry's net income appears to be on an upward trend, with a most recent value of -$61.75 million in 2025, rising from -$30.99 million in 2019. The previous period was -$50.40 million in 2024. View Xometry's forecast to see where analysts expect Xometry to go next.

Xometry's total operating income in 2025 was -$45.52 million, based on the following breakdown:

Total Gross Profit: $268.77 million
Total Operating Expenses: $314.29 million

Over the last 6 years, Xometry's total revenue changed from $80.23 million in 2019 to $686.63 million in 2025, a change of 755.8%.

Xometry's total liabilities were at $426.98 million at the end of 2025, a 17.1% increase from 2024, and a 981.0% increase since 2020.

In the past 5 years, Xometry's cash and equivalents has ranged from $15.00 million in 2025 to $86.26 million in 2021, and is currently $15.00 million as of their latest financial filing in 2025.

Over the last 6 years, Xometry's book value per share changed from 0.00 in 2019 to 5.38 in 2025, a change of 537.8%.

Related Companies

Financial statements for NASDAQ:XMTR last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Xometry (XMTR) Financials

Financials Breakdown Chart

Key Financial Trends

Xometry Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Xometry (XMTR) Financials

Annual Income Statements for Xometry

Quarterly Income Statements for Xometry

Annual Cash Flow Statements for Xometry

Quarterly Cash Flow Statements for Xometry

Annual Balance Sheets for Xometry

Quarterly Balance Sheets for Xometry

Annual Metrics And Ratios for Xometry

Quarterly Metrics And Ratios for Xometry

Financials Breakdown Chart

Key Financial Trends

Xometry Financials - Frequently Asked Questions

When does Xometry's fiscal year end?

How has Xometry's net income changed over the last 6 years?

What is Xometry's operating income?

How has Xometry's revenue changed over the last 6 years?

How much debt does Xometry have?

How much cash does Xometry have?

How has Xometry's book value per share changed over the last 6 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools